🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Adam L. Hartman

Johns Hopkins University

ORCID: 0000-0001-5672-3409

Also affiliated with Johns Hopkins Medicine, National Institute of Neurological Disorders and Stroke

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.476Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The IRDiRC Chrysalis Task Force: making rare disease research attractive to companies

Maryland law review(2023)10.1177/26330040231188979
Top 40%
0.476DataRank
Top 40%7 citations

Daria Julkowska, Mary Catherine V. Letinturier, Annemieke Aartsma‐Rus, Jennifer Austin, Juan A. Bueren +13 more

Papers

Driven by 8 papers — median percentile 60. Top paper: “GM1 gangliosidosis type II: Results of a 10-year prospective study”.

GM1 gangliosidosis type II: Results of a 10-year prospective study

Genetics in Medicine(2024)10.1016/j.gim.2024.101144
N/A
0.557DataRank · unranked
19 citations

Cristan Farmer, Jean M. Johnston, Sangwoo T. Han, David Adams, Adam L. Hartman +24 more

The IRDiRC Chrysalis Task Force: making rare disease research attractive to companies

Maryland law review(2023)10.1177/26330040231188979
Top 40%
0.476DataRank
Top 40%7 citations

Daria Julkowska, Mary Catherine V. Letinturier, Annemieke Aartsma‐Rus, Jennifer Austin, Juan A. Bueren +13 more

AAV9 Gene Therapy in GM1 Gangliosidosis Type II: A Phase 1/2 Trial

medRxiv(2025)10.1101/2025.07.28.25332074
N/A
0.212DataRank · unranked
3 citations

Precilla D’Souza, Jean M. Johnston, Maria T. Acosta, Cristan Farmer, Eva H. Baker +27 more

Deaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.46404
N/A
0DataRank · unranked
21 citations

Thomas R. Wood, Bryan A. Comstock, Krystle Perez, Semsa Gogcu, Mihai Puia‐Dumitrescu +95 more

Neonatal Outcomes in the MONEAD Study of Pregnant Women with Epilepsy

The Journal of Pediatrics X(2021)10.1016/j.ympdx.2021.100073
N/A
0DataRank · unranked
18 citations

Page B. Pennell, Carrie Brown, Adam L. Hartman, Ryan May, Thomas F. McElrath +21 more

Training Clinical Scientists

Neurology(2024)10.1212/wnl.0000000000209612
N/A
0DataRank · unranked
2 citations

Letitia A. Weigand, Stephen J. Korn, Clinton B. Wright, Adam L. Hartman

GM1 Gangliosidosis Type II: Results of a 10-Year Prospective Study

medRxiv(2024)10.1101/2024.01.04.24300778
N/A
0DataRank · unranked
5 citations

Cristan Farmer, Jean M. Johnston, Sangwoo T. Han, David R. Adams, Adam L. Hartman +23 more

Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions

medRxiv(2020)10.1101/2020.04.13.20063784
N/A
0DataRank · unranked
165 citations

William B. Klimstra, W. Paul Duprex, Adam L. Hartman, Scott C. Weaver, K.C. Plante +15 more